APRV in ALI 气道压力释放通气在急性肺损伤中的应用

合集下载

APRV气道压力释放通气

APRV气道压力释放通气

APRV 标配
标配
选配





APRV-在Evita XL中
APRV-在Evita 4 Edition中
APRV-在Evita 2 Dura中
PhigAh PRV如何设置
从Pplat 开始, 逐渐将Phigh调低 20 - 35 cmH2O
Plow 首先设为 0-5cmH2O
• 看观到察在流释放速期波病形人主动呼
气,将容量压出肺腔 -降低 Phi 直到改善 • 也可能是肺复张并恢复功 能, 提示可以逐步调低压力 及开始脱机
设置吸气压力过高
Thig设h A为P4R.5V到如5秒何设置时间?
– 可以保证建立足够的肺内压和肺容量 Tlow 很短 ( 可以从0.8秒开始调节) 观察呼出流量, 是否病人在主动呼气 维持呼气末流量在 25-50% 的呼气峰流量
呼气末流速
25% 50%
观察流速波形
适当的呼气时间(短促)
监测参数
观察增加的潮气量, 这表明肺复张改善了肺功能, 顺应性增加 调低Phigh 1-2mbar, 并延长Thigh , 同时维持自主呼吸 避免主动呼气 监测病人清醒状况, 生命体征, SaO2, EtCO2
脱机的方法是使APRV逐步切换到CPAP
专业的通气模式 -APRV(气道压力释放通气)
APRV-气道压力释放通气
气道压力释放通气模式 Airway Pressure Release Ventilation
特殊的通气模式 主要用于严重的ARDS疾病治疗
APRV-如何工作的?
A是P一R种V肺-A复R张D模S式治,疗保的持持手续段之较一高气道压力,克服肺内

无创正压通气治疗急性肺损伤

无创正压通气治疗急性肺损伤

无创正压通气治疗急性肺损伤目的:评价无创正压通气(NPPV)治疗急性肺损伤(ALI)临床治疗效果。

方法:回顾性分析我院重症监护病房(ICU)2001年1月-2010年12月救治的124例ALI 病例资料。

以时间前(2001年1月-2005年12月)后(2006年1月~2010年12月)分为对照组和治疗组,2006年1月后收治患者(治疗组)采用了NPPV治疗。

结果:治疗组NPPV治疗2、72 h后,与对照组同一时间段比较氧合指数明显增加(P<0.05),并保持较高水平,治疗组在患者滞留ICU时间、元刨通气率及住院死亡率均明显降低(P<0.05)。

结论:NPPV治疗明显降低了ALI患者有创通气率,减少了ICU滞留时间和住院死亡率。

标签:无创正压通气;急性肺损伤;效果急性肺损伤(ALl)不是单纯意义上的肺部疾病,它是全身系统炎症的肺部表现。

重度ALl则发展为急性呼吸窘迫综合征(AILDS),往往由于炎症反应和免疫调节失控,诱发或加重多器官功能不全综合征(MODS),故应早期控制ALl。

我院重症监护病房(ICU)2005年后采取鼻面罩无创正压通气(NPPV)方法治疗ALI,取得了较好的效果。

1对象与方法1.1对象2001年1月~2010年12月我院ICU共收治ALl患者124例,均符合2000年中华医学会呼吸病分会制定的《急性肺损伤,急性呼吸窘迫综合征的诊断标准(草案)》。

原发病分别有多发伤、严重感染、中毒、大手术、休克等,剔除ALI 发病时已有肺外脏器功能衰竭病例。

以前(2001年1月-2005年12月)后(2006年1月-2010年12月)分为对照组(A组,64例)和治疗组(B组,60例)。

两组一般资料比较,差异无统计学意义(P>0.05)(表1),具有可比性。

1.2设备美国Puritan-Bennett 7200型、840型呼吸机(GE公司);美国i-STAT血气分析仪(力新公司);METPM-9000多参数监护仪(迈瑞公司);随弃式硅胶面膜充气鼻面罩。

无创试题及答案

无创试题及答案

无创呼吸机考试题库一,名词解释:1,潮气量----Vt,平静呼吸时每次吸入或呼出的气量,似潮汐的涨落,称为潮气量。

2,COPD----慢性阻塞性肺疾病,是以慢性支气管炎和/或肺气肿和气流阻塞为特征的疾病,一般为进行性,可伴有气道高反应性,可能有部分可逆性。

常以气道阻塞和气道阻力增高为共同的基本特征。

3,ARDS----急性呼吸窘迫综合征,以功能残气量减少、肺顺应性降低、肺内分流增加为病理生理特点,临床表现为呼吸频速、呼吸窘迫和顽固性低氧血症的一类临床综合征。

4,PEEP----呼气末正压,是指人为地使病人气道压和肺泡内压在呼气末保持高于大气压的水平。

5,FRC----功能残气量,平静呼气末尚留于肺内的气量,是残气量和补呼气量之和。

6,CPAP---持续气道正压,当病人自主呼吸时,在气道开口处施加固定的正压,使气道内在整个呼吸周期(包括呼气末)都维持正压。

7,PSV----压力支持通气,是一种压力-目标或压力-限制性通气模式,每次通气均由病人触发并由呼吸机给予支持最后由病人来结束。

8,Peep i---内源性呼气末正压,是病人自身因素或机械通气应用不当引起的,在呼气末肺泡内产生的一定程度的正压。

9,动脉血氧分压(PaOz):是血液中物理溶解的氧分子所产生的压力。

正常范围为12.6~13.3 kPa(95~100 mmHg),主要临床意义是判断有无缺氧及其程度。

10,动脉血氧饱和度(SaOz):指动脉血氧与Hb结合的程度,即单位Hb含氧百分数,正常范围为95%~98%。

11,pH值:表示体液中氢离子浓度[H+]的指标或酸碱度,正常范围为7.35~7.45.12,呼吸衰竭:是各种原因引起的肺通气和(或)换气功能严重障碍,以致在静息状态下亦不能维持足够的气体交换,导致缺氧伴(或不伴)二氧化碳潴留,从而引起一系列生理功能和代谢紊乱的临床综合征。

13,I型呼吸衰竭:缺氧而无COz潴留(PaO2:<60 mmHg,PaC02降低或正常)。

呼吸机通气模式全

呼吸机通气模式全

1、胸廓肺组织的弹性阻力,气体在呼吸道运动产生的以摩擦力为主的非弹性阻力2、间歇正压通气:(IPPV)也称机械控制通气CMV是呼吸机最基本的通气模式之一。

此方式时,呼吸机不管病人自己呼吸的情况如何,均按预调的通气参数为病人间歇正压通气。

主要用于无自主呼吸的病人。

3、叹息的应用(SIGH):在IPPV期间,每隔一定的IPPV或时间,供给一个1.5-2倍的潮气量。

目的在于预防长期IPPV时肺泡凹陷性肺不张。

实际上是模仿人体在正常安静呼吸一段时间后有1-3次深呼吸设计的。

4、同步间歇正压通气(SIPPV):在于病人自主吸气触发呼吸机供给IPPV通气。

5、间歇指令性通气(IMV):在病人自主呼吸的同时,间断给予IPPV通气,即自主呼吸+IPPV。

自主呼吸的气流由呼吸机的持续大流量恒流供给。

IPPV由呼吸机按预调的频率、潮气量、吸气时间供给。

总分钟通气量等于机械MV+自主呼吸MV。

6、分钟指令性通气(MMV);在撤机过程中,自主呼吸不稳定的患者,IMV并不能保证其获得恒定的通气,故设想研制一个每分钟通气量恒定的系统,以保证同期不稳定的患者在撤机的过程中的安全。

当患者自主呼吸降低时,该系统会主动增加机械通气的水平;相反,恢复自主性呼吸的患者,在没有改变呼吸机参数的情况下会自动将通气水平越降越低。

7、呼气末正压(PEEP):吸气由病人自发或呼吸机产生。

而呼气末借助于装在呼气端的限制气流活瓣等装置,使气道压力高于大气压。

8、持续气道正压(CPAP):是在自主呼吸条件下,整个呼吸周期过程中气道内均保持正压的通气模式。

病人通过按需活瓣或快速、持续正压气流系统进行自主呼吸,正压气流>吸气气流,呼气活瓣系统对呼出气流给予一定的阻力(多用对射气流或(和)球囊活瓣)使吸气期和呼气期气道压均大于大气压。

呼吸机内装有灵敏的气道压测量和调节系统,随时调整正压气流的流速,维持气道压基本恒定在预调的CPAP水平,波动较小。

9、压力支持通气(PSV):自主呼吸期间,病人吸气相一开始,呼吸机即开始送气并使气道压迅速上升到预置的压力值,并维持气道压在这一水平。

无创通气在急性肺损伤中的应用

无创通气在急性肺损伤中的应用

无创通气在急性肺损伤中的应用目的:探讨无创正压通气(NPPV)治疗急性肺损伤(ALI)中的临床应用价值及安全性。

方法:回顾性分析2011-2012年笔者所在医院收治的52例确诊为ALI患者的临床资料,所有患者均行NPPV治疗。

观察治疗前后患者心率(HR)、呼吸频率(RR)、氧合指数(OI)、动脉血CO2/O2分压(PaCO2/PaO2)及血氧饱和度(SaO2)的变化。

结果:本组患者NPPV治疗成功率为94.2%(49/52),有创通气5.8%(3/52),发生ARDS比例为1.9%(1/52),NPPV治疗后HR、RR、OI、PaCO2、PaO2及SaO2显著优于治疗前,差异有统计学意义(P<0.05)。

结论:NPPV能显著提高ALI治疗的成功率,在无NPPV禁忌证的情况下,该方法是治疗ALI高效、安全的方法。

标签:无创通气;急性肺损伤;临床效果无创通气由于具有无创和并发症少的优点,而被广泛用于多种急、慢性呼吸衰竭的治疗中。

当患者呼吸力学异常、呼吸肌疲劳等问题明显,且痰液引流问题又相对次要时,是应用无创通气的最佳时机[1]。

诱发ALI的直接和间接因素众多,其中最为关键的因素是肺泡上皮细胞及毛细血管内皮细胞损伤,造成弥漫性肺间质及肺泡水肿,导致的急性低氧性呼吸功能不全,临床治疗不及时将会发展成为ARDS,增加ALI的死亡率[2]。

本文将NPPV应用于临床治療中,通过观察治疗前后患者临床症状改善情况,探讨NPPV在ALI治疗中的临床应用价值和安全性。

1 资料与方法1.1 一般资料2011年10月-2012年10月笔者所在医院ICU共收治ALI患者52例,男35例,女17例,年龄18~75岁,平均(42.7±2.6)岁。

肺损伤原因中交通伤23例,挤压伤11例,暴力打击伤15例,其他3例,从发病到入院接受治疗时间在12 h内,平均时间(5.7±1.5)h,AIS胸部创伤评分(3.49±1.32)分,创伤严重度ISS评分(29.18±7.35)分;纳入标准:(1)所有患者均符合《急性肺损伤/急性呼吸窘迫综合征的诊断标准(2003版)》,未见严重颅脑损伤致神志不清或创伤致休克者;(2)年龄在18~75岁,性别不限,动脉血氧分压低于正常值,且吸氧后未见缓解;(3)急性起病,PaO2/FiO2≤300 mm Hg,胸部X线片或胸部CT可见浸润影,心功能超声检查显示左心功能正常,未见严重心律失常、心肌缺血或脏器功能不全者。

呼吸机相关性文献

呼吸机相关性文献

(APRV)压力释放通气(九、压力释放通气患者接受恒定水平的正压和进行自主呼吸主呼吸,,正压按医生设置的频率周期性释放和立即重建性释放和立即重建。

本图中压力释放到0。

气道压力释放通气APRVAPRV 的初始设置设置恰当的FiO 2以维持PaO 2≥60mmHg ;设置CPAP 初始为20cmH 2O ;EEP (FRC ):0~10cmH 2O ;T E 固定于1.5秒至呼气时间常数的3倍或3倍以上(呼气时间常数等于气道阻力×肺顺应性)以避免PEEPi 的产生。

APRV 频率设置于4~8次/分,取决于镇静的情况。

APRV 缺点对于顺应性差的患者对于顺应性差的患者,,应用APRV 的效果尚未评价效果尚未评价。

严重气流阻塞患者不能应用APRV 。

必须仔细监测每分通气量必须仔细监测每分通气量。

如果呼吸频率增至30次/分,可产生过高的PEEPi 。

十、双相气道正压双相气道正压((Biphasic Positive Airway Pressure BIPAP )应用BIPAP 时,采用高压力相的时间(TPhi )和低压力相的时间和低压力相的时间((TPlo )是可以根据需要选择的,双压力相的时间比可称为相时比(Phase -time Ratio ,PhTR ),即PhTR =TPhi /TPlo 。

通常采用PhTR =1:2;如果采用PhTR =2:1,即类似于反比通气的概念应用于BIPAP 模式模式,,可称为反比BIPAP (IR -BIPAP )。

应用BIPAP 模式比应用CPAP 对增加患者的氧合具有更明显作用氧合具有更明显作用。

近年临床应用的经验表明:在疾病的各个阶段在疾病的各个阶段,,均可用BIPAP 模式作为患者自主呼吸的通气辅助为患者自主呼吸的通气辅助、、操作简单方便且无创伤性无创伤性。

但一般认为BIPAP 和APRV 仅适应用轻中度呼吸衰竭用轻中度呼吸衰竭,,因为它提供的机械辅助功并不是很高的并不是很高的。

APRV通气模式介绍-基本使用及管理

APRV通气模式介绍-基本使用及管理机械通气的气道压力释放通气(APRV)模式是在定时压力释放的情况下升高CPAP水平。

该模式允许自主呼吸。

这些呼吸可以是不受支持的,也可以是压力支持的,或者是由自动管道补偿支持的。

它们的关键是回路中的动态呼气阀,允许在高肺容量下自主呼吸。

虽然使用APRV可以充分支持任何患者,但通常用于需要肺泡复张以维持氧合的患者,例如ARDS(以及其他治疗方法,例如吸入前列环素,神经肌肉阻滞,PEEP和俯卧位)。

APRV通气适应症急性肺损伤(ALI/ARDS)弥漫性肺炎肺不张需要超过50%的FIO2气管食管瘘初始APRV设置PPlateau(或所需PMean+3 cmH2O)处的PHigh。

如果您从不同的模式切换到APRV,那么PHigh可以设置为之前的平均气道压力。

一个好的起始水平应该是28cmH2O。

更高的跨肺泡压力会复张额外的肺泡,但是,尽量将PHigh保持在35cmH2O以下。

THigh为4.5-6.0秒。

这是吸气时间。

呼吸频率应为每分钟8 ~ 12次——不能超过。

PLow为0 cmH2O,以优化呼气流量。

大的压力梯度允许在非常短的呼气时间内进行潮气通气。

TLow在0.5-0.8秒。

呼气时间应足够短,以防止去复张,并足够长,以获得适当的潮气量。

潮气量目标介于4和6 mL/kg之间。

如果潮气量不足,呼气时间延长;如果潮气量过高(> 6 mL/kg),呼气时间缩短。

如果自主呼吸,应启用自动管道补偿(ATC)功能。

与压力控制-反比通气(PC-IRV)一样,APRV利用较长的“吸气时间”(THigh)复张肺泡并优化气体交换。

打开的呼气阀允许在THigh期间自主呼吸。

APRV有助于呼吸肌的休息和膈肌的利用。

一旦应用了初始设置,希望胸前肌的使用要少得多,而膈肌则要做大部分的工作。

这应该发生在设置APRV后的几个小时内。

患者在复张时呼吸应该更舒服。

使用APRV越早,肺复张越有效,越有可能耐受。

气道压力释放通气-APRV

⽓道压⼒释放通⽓-APRV这是对有创通⽓模式⽓道压⼒释放通⽓(APRV)的介绍。

我的理解正在演变,我试图将驱动压⼒的最新概念纳⼊我的知识中。

在我努⼒将新思维和理解整合到ARDS管理中时,我希望收到关于这些想法的⼀些反馈。

那么什么是APRV?在最简单的⽔平上,APRV是持续⽓道正压通⽓(CPAP)的⼀种形式,其利⽤CPAP释放间歇性达到零压⼒。

这些CPAP释放到零的模式代表了严重的反⽐通⽓。

APRV的第⼆个⽅⾯是释放到0(呼⽓)⾮常短暂,通常为0.25⾄1秒。

压⼒释放或呼⽓相的短暂性与长吸⽓时间或吸⽓-呼⽓⽐(I:E⽐值)对APRV技术同样重要。

什么是反⽐通⽓?在正常静息状态下,我们呼⽓所需的时间⽐吸⽓所需的时间长,例如,1秒吸⽓,2秒呼⽓。

这是由⼩⽓道直径随胸内压变化引起的。

吸⽓产⽣相对负的胸内压,将⼩⽓道拉开,增加其直径,与呼⽓相⽐,导致流量增加。

在呼⽓过程中,胸内压相对升⾼,减⼩了⼩⽓道直径,从⽽减⼩了⽓流。

I:E⽐值是动态的,受患者个体病理的影响。

作为传统的经验法则,我们为此将呼吸机的⽐例设定为1:2。

那么,我们为什么要做相反的事情呢?想象⼀组肺泡,⼀半肺泡因⽔肿或渗出液⽽膨胀不全(塌陷),另⼀半肺泡开放。

现在想象⼀下,这些肺泡正在以传统的1:2的⽐例接受⽓体流速。

健康肺泡的体积随潮⽓量的增加⽽增加和减少。

然⽽,肺不张肺泡仅在潮⽓呼吸结束时开始开放,然后再次塌陷,容量和压⼒的应⽤时间不⾜以在呼吸周期内保持开放。

肺泡打开所需的时间被描述为⼀个时间常数,但是,在⼤部分肺组织不张的缺氧患者中,塌陷肺和健康肺之间的时间常数不同。

反⽐通⽓的想法是增加吸⽓时间,使时间常数较慢的肺区(塌陷/肺不张区)有⾜够的时间打开。

因此,您要问的下⼀个问题是,为什么呼⽓时间这么短?使⽤反⽐,我们克服了肺的不同部分具有不同时间常数且不能保持肺泡开放⾜够长的时间以促进⽓体交换的问题。

下⼀个问题是保持我们现在复张的肺泡开放,这通常是通过呼⽓末正压(PEEP)实现的。

机械通气参数的设置和调整

双相气道正压:是指自主呼吸时,交替给予 两种不同的气道正压。基本的呼吸方式是CPAP, 但CPAP水平不是恒定的。
双水平的气道正压:是指经面(鼻)罩进行的 一种无创性通气方式,其基本的通气模式相当于 PSV+PEEP。
伺服控制通气模式(servo-controlled modes),又称自动反馈-调节模式。
PaCO2升高15-20mmHg,pH<7.20-7.25。 出现意识障碍、昏迷。 无力咳痰、窒息。 急性左心衰,低氧经一般治疗无效。 诊断为ARDS。
需要注意的几个问题
参数的设定应以病人的病理生理基础和临床 具体情况为基础。
通气机参数和通气模式的选择应该以明确治 疗终点(therapeutic end points)作为指导。
新的通气模式:指令每分钟通气(MMV)、分 侧肺通气(ILV)、气道压力释放通气(APRV)、 压力调节容量控制通气(PRVCV)、容量支持通气 (VSV)、容量保障压力支持通气(VAPS)、液体通 气(LV)、成比例通气(PAV)、适应性支持通 气(ASV)、适应性压力通气(APV)。
通气模式的选择常根据医院的习惯倾向、医 师的熟悉程度来决定,没有一个适用于所有临床 病人和所有疾病的最好通气模式。
压力限制通气,吸气流量波形总是成指数下 降的,下降率取决于压力范围和肺的阻抗。
阻力增加时,流量下降缓慢,顺应性降低或吸气 时间延长时,流量下降比较迅速,吸气末可能存 在流量为零的阶段。
有些研究已表明,应用压力限制通气时氧合改善, 这可能是由于减速流量波形和应用这种通气模式 时平均气道压较高的结果。
PSV可以和SIMV一起应用,此时在两次指 令呼吸之间的自主呼吸是压力支持。低水平 的压力支持(合用或不合用SIMV)可用以克服 气管内导管或老一代通气机中反应性差的按 需阀引起的阻力。

成人呼吸窘迫综合征(ards)名词解释

成人呼吸窘迫综合征(ards)名词解释1. 引言1.1 概述成人呼吸窘迫综合征(Acute Respiratory Distress Syndrome,ARDS)是一种严重的急性呼吸系统疾病,其主要特点是肺功能受限,导致气体交换障碍。

ARDS通常发生在全身性炎症反应综合征(SIRS)的基础上,并伴随着肺充血和肺水肿等病理生理变化。

ARDS 的发病率逐年递增,在临床急诊中占据重要地位。

早期发现和及时治疗对患者的生存率和恢复有着至关重要的影响。

因此,深入了解ARDS 的定义、病理生理特点、临床表现、诊断标准、发病机制以及治疗和护理措施具有重要意义。

1.2 文章结构本文将从不同方面对ARDS 进行全面解析。

首先,我们会介绍ARDS 的定义和其与其他相关呼吸系统疾病的区别。

接着,将详细描述ARDS 的病理生理特点以及流行病学数据,以帮助读者更好地了解该综合征。

在了解ARDS 的基本特点后,我们还将探讨其临床表现和诊断标准。

这一部分包括了患者的常见症状和体征,以及医生在诊断ARDS 时所依据的标准和方法。

同时,我们也会介绍与ARDS 相似的其他疾病,以帮助读者进行鉴别诊断。

在明确了ARDS 的定义、特点和诊断标准后,我们将深入探讨其发病机制和病因分析。

这一部分将涉及ARDS的致病机制、常见的危险因素以及预后因素评估方法。

通过对这些方面的综合分析,有助于提高对ARDS发生的认知,并采取相应的预防措施。

最后,在全面了解了ARDS之后,我们将介绍该疾病治疗和护理方面的措施。

这包括支持性治疗措施、特异性治疗手段(例如体外膜肺氧合)以及康复管理等。

这些信息对于医务人员提供适当而有效的处理方法至关重要。

1.3 目的本文旨在为读者提供全面的关于成人呼吸窘迫综合征(ARDS)的知识。

通过对ARDS的定义、病理生理特点、临床表现和诊断标准的详细介绍,帮助读者加深对该疾病的认识。

此外,通过深入分析ARDS发病机制和病因,并提供治疗和护理措施,使读者能够更好地应对该疾病,并为患者提供适当的护理和治疗方案。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Am J Respir Crit Care Med Vol 164. pp 43–49, 2001Internet address: Improved gas exchange has been observed during spontaneous breathing with airway pressure release ventilation (APRV) as com-pared with controlled mechanical ventilation. This study was de-signed to determine whether use of APRV with spontaneous breathing as a primary ventilatory support modality better pre-vents deterioration of cardiopulmonary function than does initial controlled mechanical ventilation in patients at risk for acute respi-ratory distress syndrome (ARDS). Thirty patients with multiple trauma were randomly assigned to either breathe spontaneously with APRV (APRV Group) (n ϭ 15) or to receive pressure-con-trolled, time-cycled mechanical ventilation (PCV) for 72 h followed by weaning with APRV (PCV Group) (n ϭ 15). Patients maintained spontaneous breathing during APRV with continuous infusion of sufentanil and midazolam (Ramsay sedation score [RSS] of 3). Ab-sence of spontaneous breathing (PCV Group) was induced with sufentanil and midazolam (RSS of 5) and neuromuscular blockade.Primary use of APRV was associated with increases (p Ͻ 0.05) in respiratory system compliance (C RS ), arterial oxygen tension (Pa O 2 ), cardiac index (CI), and oxygen delivery (D O 2 ), and with reductions(p Ͻ 0.05) in venous admixture ( VA / T ), and oxygen extraction.In contrast, patients who received 72 h of PCV had lower C RS , Pa O 2 ,CI, D O 2 , and VA / T values (p Ͻ 0.05) and required higher doses of sufentanil (p Ͻ 0.05), midazolam (p Ͻ 0.05), noradrenalin (p Ͻ 0.05), and dobutamine (p Ͻ 0.05). C RS , Pa O 2 , CI and D O 2 were low-est (p Ͻ 0.05) and VA / T was highest (p Ͻ 0.05) during PCV. Pri-mary use of APRV was consistently associated with a shorter dura-tion of ventilatory support (APRV Group: 15 Ϯ 2 d [mean Ϯ SEM];PCV Group: 21 Ϯ 2 d) (p Ͻ 0.05) and length of intensive care unit (ICU) stay (APRV Group: 23 Ϯ 2 d; PCV Group: 30 Ϯ 2 d) (p Ͻ 0.05). These findings indicate that maintaining spontaneous breathing during APRV requires less sedation and improves car-diopulmonary function, presumably by recruiting nonventilated lung units, requiring a shorter duration of ventilatory support and ICU stay.Acute respiratory distress syndrome (ARDS) causes alveolar collapse primarily in dependent lung regions adjacent to the dia-phragm, resulting in intrapulmonary venous admixture of blood ( VA / T ) and severe arterial hypoxemia (1). Mechanical ven-tilation with positive end-expiratory pressure (PEEP) and low tidal volume (V T ) is commonly applied during ARDS to re-cruit collapsed alveoli for gas exchange without hyperinflation of the lungs (2, 3). Despite early mechanical ventilation with PEEP, a high number of patients at risk have been observed to develop ARDS (4). An improvement in ventilation-perfusion ( A /) matching has been considered an advantage of partial ventilatory sup-Q ·Q ·Q ·Q ·Q ·Q ··Q ·Q V ··Q port as compared with controlled mechanical ventilation (5–7),presumably because the diaphragmatic contraction augments distribution of ventilation to dependent, poorly aerated but per-fused lung regions (8). Spontaneous breathing in any phase of the mechanical ventilator cycle is possible with airway pressure release ventilation (APRV), which ventilates by periodic switching between two levels of continuous positive airway pressure (CPAP) (9, 10). Recently, we observed that patients with severe ARDS exhibited better A / matching and arte-rial oxygenation, during spontaneous breathing with APRV than during controlled mechanical ventilation (11). However,it is not known whether maintaining spontaneous breathing from the very beginning of ventilatory support may preventalveolar collapse and thereby reduce VA / T and hypoxemia in patients at risk for ARDS.We hypothesized that in patients at risk for ARDS, sponta-neous breathing with APRV prevents deterioration of gas exchange or allows it to recover faster than does controlled mechanical ventilation. To test this hypothesis, we examined car-diopulmonary function in patients with severe multiple trauma who were either allowed to breathe spontaneously during APRV or were given full ventilatory support for 72 h and then weaned with APRV.METHODSThe study protocol was approved by the Innsbruck Ethics Committee.In accordance with Austrian federal law, the independent Innsbruck Ethics Committee waived the need for informed consent by the pa-tients in the study, given that all were unconscious and approved ven-tilatory modalities were used.Thirty mechanically ventilated patients with severe multiple trauma, as indicated by an injury severity score (ISS) (12) above 40,were studied. Patients were not included in the study if they had chronic lung or heart disease, bronchopleural fistula, or severe cere-bral injury. The criteria of the American–European Consensus Con-ference were used to define acute lung injury (ALI) and ARDS (13).Sepsis was defined by the criteria of the American College of Chest Physician and the Society of Critical Care Medicine Consensus Con-ference Committee of 1992 (14). Organ failure was defined with the scoring system described by Knaus and colleagues (15). Severity of ill-ness was assessed with the Simplified Acute Physiologic Score (16).Routine clinical management of the patients included the use of a radial artery catheter and a thermistor-tipped quadruple-lumen pul-monary artery catheter (CCO 746HF8; Baxter Edwards Critical Care,Irvine, CA).Cardiovascular MeasurementsHeart rate (HR) was obtained from the electrocardiogram. Systemic blood pressure (Psa), central venous pressure (Pcv), pulmonary artery pressure (Ppa), and pulmonary artery occlusion pressure (Ppao) were transduced (P50; Gould, Oxnard, CA) and recorded. Cardiac output (CO) was continuously estimated with the thermal dilution technique (Vigilance; Baxter Edwards Critical Care, Irvine, CA). In addition, in-termittent determinations of CO were made with 10 ml of iced 0.9%saline solution as indicator and by averaging seven determinations made at random moments during the ventilatory cycle.V ··Q ·Q ·Q ( Received in original form January 21, 2000 and in revised form August 17, 2000 )Supported by the Lorenz Boehler Trauma Foundation.Correspondence and requests for reprints should be addressed to ChristianPutensen M.D., Department of Anesthesiology and Intensive Care Medicine,University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. E-mail:putensen@uni-bonn.deLong-Term Effects of Spontaneous Breathing During Ventilatory Support in Patients with Acute Lung InjuryCHRISTIAN PUTENSEN,SABINE ZECH,HERMANN WRIGGE,JÖRG ZINSERLING,FRANK STÜBER,TILMANN VON SPIEGEL,and NORBERT MUTZDepartment of Anesthesiology and Intensive Care Medicine, University of Bonn, Bonn, Germany; and Department of Anesthesia and Intensive Care Medicine, University of Innsbruck, Innsbruck, Austria44AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 1642001Ventilatory and Lung Mechanics MeasurementsGas flow and airway pressure were measured at the proximal end of the tracheal tube with a heated pneumotachograph (No. 2; Fleisch,Lausanne, Switzerland) connected to a differential pressure trans-ducer (P130; Statham, Oxnard, CA). V T was derived from the inte-grated gas flow signal. End-inspiratory pressures were measured after a 5-s end-inspiratory occlusion, and intrinsic positive end-expiratory pressures (PEEPi) were measured after a 5-s end-expiratory occlusion of the airway as described previously (17). Respiratory system compli-ance (C RS ) was obtained during transient neuromuscular blockade with intravenous vecuronium bromide in a dose of 0.1 mg/kg by divid-ing expiratory V T by the difference between end-inspiratory Paw and PEEPi. A static pressure–volume (P–V) curve of the total respiratory system was constructed on a daily basis for each patient during tran-sient neuromuscular blockade (18, 19). The lower inflection pressure (LIP) was defined as the lowest and the upper inflection pressure (UIP) as the highest Paw at which the slope of the static inflation P–V curve was maximal (18, 19). A computerized step-by-step regression analysis was used to quantify LIP and UIP as described previously (20).Gas AnalysisArterial and mixed venous blood gases (oxygen tension [P O 2 ], and carbon dioxide tension [P CO 2 ]) and pH were determined in duplicate,immediately after sampling, with standard blood gas electrodes (STAT5Profil; Nova Biomedical, Waltham, MA). Each sample had oxygen saturation and hemoglobin analyzed spectrophotometrically (OSM3; Radiometer, Copenhagen, Denmark). Fractions of inspired and expired O 2 and CO 2 (F IO 2 and F EO 2 , and F ICO 2 and F ECO 2 , respec-tively) were continuously measured (Deltatrac; Datex, Helsinki, Fin-land).Data AnalysisStandard formulas were used to calculate cardiac index (CI), systemic vascular resistance (SVR), VA / T , oxygen delivery (D O 2 ), and oxy-gen extraction ratio (O 2ER ). Oxygen consumption ( O 2 ) was calcu-lated as (V I и F IO 2 ) Ϫ (V E и F EO 2 ).ProtocolAfter inclusion in the study, all patients remained supine. Adequate fluid supply was ensured with infusion of lactated Ringer’s solution to achieve a Ppao of 14 to 18 mm Hg. Albumin 5% solution was given to maintain serum albumin concentrations above 2.0 g/dl, and packed red blood cells were given to achieve a hemoglobin of at least 10 g/dl.Dobutamine was infused when, despite fluid replacement, CI fell be-low 3.0 L/min/m 2 , and was given to achieve a CI of 3.5 to 4.0 L/min/m 2 .Norepinephrine infusion was added if SVR was below 600 dyn и s/cm Ϫ 5 , to restore a mean Psa of 70 to 80 mm Hg. In the presence of oliguria, dopamine infusion was added at a fixed rate of 3 ␮ g/kg/min.Pressure-limited ventilatory support was provided with the de-mand-valve CPAP circuit of a standard ventilator (Evita; Dräger,Lübeck, Germany). The low pressure level was set at 2 cm H 2 O above LIP on a static P–V curve, and the upper pressure level was adjusted to the value below UIP that produced a V T of less than 7 ml/kg during transient neuromuscular blockade. Airway pressure limits were read-justed on a daily basis according to the P–V curve. The ventilator rate was set to maintain Pa CO 2 at 45 to 55 mm Hg. The duration of the up-per and lower pressure levels was always adjusted to allow flow to de-celerate to zero, and the resulting inspiratory-to-expiratory ratio was kept constant. F I O 2 was adjusted to maintain Pa O 2 above 60 mm Hg.After obtaining baseline measurements, we randomly assigned pa-tients to receive APRV with spontaneous breathing (APRV Group)or pressure-limited, time-cycled, controlled mechanical ventilation (PCV) for 72 h followed by weaning with APRV (PCV Group). Note that from a mechanical standpoint, APRV without spontaneous breath-ing was identical to PCV. In the APRV Group, all patients maintained spontaneous breathing during ventilatory support with continuous in-fusion of sufentanil and midazolam as required to achieve a Ramsay sedation score (RSS) of 3 (21). To assess cardiopulmonary function during APRV in the absence of spontaneous breathing, we gave pa-tients in the PCV Group continuous infusions of sufentanil and mida-zolam as required to achieve an RSS of 5 to 6, and paralyzed them with intravenous vecuronium bromide at 0.1 mg/kg for 72 h. Neuro-Q .Q .V ·muscular blockade was considered sufficient with disappearance of the twitch response to a train of four supramaximal ulnar nerve stimu-lations at 2.0 Hz for 1.5 s every 2 min (Myograph 2000; Organon Teknika, Boxtel, The Netherlands). Then, in patients of the PCV Group, infusion of midazolam and sufentanil was reduced to achieve an RSS of 3, and spontaneous breathing was allowed with APRV.All patients were weaned according to a strict protocol by decreas-ing the APRV rate twice daily. Clinical tolerance of weaning was con-sidered poor and ventilatory support was increased when patients de-veloped a respiratory rate Ͼ 35 breaths/min, pH Ͻ 7.25, Sa O 2 Ͻ 90%,HR Ͼ 140 beats/min or a sustained increase or decrease in HR of more than 20%, systolic Psa Ͼ 180 mm Hg or Ͻ 90 mm Hg, increased accessory muscle activity, diaphoresis, and facial signs of distress (22).Patients were extubated when they breathed comfortably with 5 cm H 2 O CPAP for 6 h.Measurements including arterial blood gas analysis and data col-lection were made under stable conditions as confirmed by constancy( Ϯ 5%) of E , Sa O 2 , F ECO 2 , Psa, Ppao, and CI for at least 30 min at 8-h intervals over a period of 10 d. Cardiopulmonary variables were aver-aged for each 24-h period.Endpoints and Statistical AnalysisThe primary endpoints of the study were the effects of primarily par-tial ventilatory support on cardiorespiratory function within 10 d after ICU admission. The secondary endpoints were duration of ventilatory support, intubation, and ICU stay.Results are expressed as mean Ϯ SEM. Data were tested for nor-mal distribution with the Shapiro–Wilks W test and were analyzed by two-way analysis of variance (ANOVA), with the initial ventilatory modality as the between-group factor and time after randomization as the repeated-measures factor. When a significant F ratio was ob-tained, differences between the means were isolated with the post hoc Newman–Keuls multiple comparison test. Clinical characteristics of the two groups were compared through a one-way ANOVA. Differ-ences were considered statistically significant if p Ͻ 0.05.RESULTSThere were no statistically significant differences between the two study groups in their demographic (Table 1) or clinical data (Figures 1 through 4) at baseline.In all patients, LIP and UIP could be identified on the static P–V curve (Figure 1). Ventilatory variables, ventilator settings,and lung mechanics are shown in Figure 2. Patients were ini-tially mechanically ventilated with an essentially identical low Paw limit (APRV Group: 12 Ϯ 1 cm H 2 O; PCV Group: 12 Ϯ 1V ·TABLE 1.DEMOGRAPHIC DATA AND CLINICAL CHARACTERISTICS AT INCLUSION INTO THE STUDY*APRV GroupPCV Group p Value Number of patients, n (%)15 (100)15 (100)Age, yr40 Ϯ 542 Ϯ 6nsGender, M/F 11/413/2ns ISS 50 Ϯ 249 Ϯ 2ns SAPS18 Ϯ 118 Ϯ 1ns ARDS, n (%)2 (14)3 (21)ns ALI non ARDS, n (%)6 (40) 5 (33)ns Extrapulmonary organ failure, n (%) †ns 1 6 (30) 5 (30)ns 2 1 (7) 1 (7)ns у 30 (0)0 (0)ns Sepsis, n (%)0 (0)0 (0)ns Ventilatory support before entry, h6 Ϯ 16 Ϯ 1nsDefinition of abbreviations : ALI ϭ acute lung injury (13); ARDS ϭ acute respiratory distress syndrome (13); F ϭ female; ISS ϭ injury severity score (12); M ϭ male; SAPS ϭ simplified acute physiologic score (16).* Values are mean Ϯ SEM. †Defined by the multi-organ failure score described by Knaus and colleagues (15)Putensen, Zech, Wrigge, et al. : Maintaining Spontaneous Breathing During APRV45cm H 2 O), upper Paw limit (APRV Group: 26 Ϯ1 cm H 2O;PCV Group: 26 Ϯ 1 cm H 2O), and ventilatory rate (APRV Group: 16 Ϯ2 breaths/min; PCV Group: 16 Ϯ 2 breaths/min),resulting in similar values of E (APRV Group: 9.9 Ϯ 0.4 L;PCV Group: 10.2 Ϯ 0.3 L) and C RS (APRV Group: 40 Ϯ 3 ml/cm H 2O; PCV Group: 40 Ϯ 2 ml/cm H 2O). In the APRV Group, a lower upper limit of Paw and ventilatory rate (p Ͻ0.05) and an unchanged lower limit of Paw resulted in an es-sentially equal total E and a higher compliance (p Ͻ 0.05)than in the PCV group. The highest upper Paw limit (p Ͻ0.05) and lowest compliance (p Ͻ 0.05) were observed in theV ·V ·absence of spontaneous breathing. When patients in the PCV group were switched to APRV with spontaneous breathing af-ter the initial 72-h period, the upper Paw limit and ventilatory rate could be reduced (p Ͻ 0.05), whereas total E remained unchanged and C RS increased (p Ͻ 0.05). In the APRV-group,spontaneous breathing during APRV accounted for 10 Ϯ 2%of the total E on Day 1, which increased to 35 Ϯ 9% by Day 10 (p Ͻ 0.05). In the PCV Group, spontaneous breathing be-gan by accounting for 8 Ϯ 2% of total E on Day 4, which in-creased to 20 Ϯ 3% by Day 10 (p Ͻ 0.05). Spontaneous E and respiratory rate were always higher in the APRV Group than in the PCV Group (p Ͻ 0.05). PEEPi and V T were not significantly different for the two groups.Changes in cardiovascular variables are shown in Figure 3.CI was higher (p Ͻ 0.05) and SVR and PVR lower (p Ͻ 0.05)in the APRV Group than in the PCV Group. CI was lowest in the absence of spontaneous breathing (p Ͻ 0.05). When spon-taneous breathing was allowed during APRV on Day 4 in the PCV Group, CI increased (p Ͻ 0.05). HR, Psa, Pcv, Ppa, and Ppao were not significantly different in the two groups.Maintaining spontaneous breathing with APRV was asso-ciated with a lower VA /T (p Ͻ 0.05) and a higher Pa O 2/F I O 2(p Ͻ 0.05) and D O 2 (p Ͻ 0.05) than was seen in the PCV Group (Figure 4). Despite spontaneous breathing in the APRV Group, O 2 was comparable to that of patients receiving full ventilatory support, and O 2ER was lower (p Ͻ 0.05). Pa O 2/F I O 2(p Ͻ 0.05) and D O 2 (p Ͻ 0.05) were lowest and VA /T was highest in the absence of spontaneous breathing (p Ͻ 0.05).Arterial pH, Pa CO 2, Sa O 2, Sv O 2, and O 2 were comparable in the two groups.Less sufentanil (p Ͻ 0.05) and midazolam (p Ͻ 0.05) was administered to patients breathing spontaneously with APRV than to patients receiving full ventilatory support in the initial 72 h (Figure 5). The highest doses of sufentanil and midazolamV ·V ·V ·V ··Q ·Q V ··Q ·Q V·Figure 1.Low and high inflection pressures identified on static P–V curves at baseline (BL) and for 10 d in patients immediately breathing spontaneously with APRV (APRV Group) (open circles ) or ventilated with a pressure-controlled, time-cycled mechanical mode for 72 h and then weanned with APRV (PCV Group) (closed squares ). Values are mean ϮSEM.Figure 2.Low and high air-way pressure, spontaneous (E spon) and total minute ventilation (E ), compliance,and ventilator rate at base-line (BL) and for 10 d in patients immediately breath-ing spontaneously with APRV (APRV Group) (open circles )or ventilated with a pres-sure-controlled, time-cycled mechanical mode for 72 h and then weaned with APRV (PCV Group) (closed squares ).Values are mean Ϯ SEM. †p Ͻ0.05 between groups, *p Ͻ0.05 between groups at the same time point, ‡p Ͻ0.05 compared with Days 1, 2, or 3 within the same group.V ·V ·46AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 1642001were required to adapt patients to controlled mechanical ven-tilation during the first 3 d in the PCV Group (p Ͻ 0.05). Simi-larly, less noradrenaline (p Ͻ 0.05) and dobutamine (p Ͻ 0.05)were required to achieve the desired cardiovascular function in the APRV Group.The incidence of ARDS was highest in the the PCV Group within the first 10 d after admission to the ICU. In contrast, the in-cidence of ALI was higher in patients who from the beginning breathed spontaneously with APRV. Durations of ventilatory support (p Ͻ 0.05), intubation (p Ͻ 0.05), and ICU stay (p Ͻ 0.05)were shorter in patients in whom spontaneous breathing with APRV was used as the primary ventilatory modality (Table 2).DISCUSSIONThis study was designed to evaluate the effect of spontaneous breathing with APRV on gas exchange and cardiovascular function in patients at risk for ARDS. When spontaneous breathing was allowed from the beginning of ventilatory sup-port, gas exchange improved, as reflected by a higher Pa O 2/F I O2Figure 3.CI, Ppao mean Psa, and Ppa at baseline (BL) and for 10 d in patients immediately breathing spon-taneously with APRV (APRV Group)(open circles ) or ventilated with a pressure-controlled, time-cycled me-chanical mode for 72 h and then weaned with APRV (PCV Group)(closed squares ). Values are mean ϮSEM. †p Ͻ 0.05 between groups, *p Ͻ0.05 between groups at the same time point, ‡p Ͻ 0.05 compared withDays 1, 2, or 3 within the same group.Figure 4.Pa O 2/F I O 2 ra-tio, Pa CO 2, D O 2, and O 2at baseline (BL) and for 10 d in patients imme-diately breathing spon-taneously with APRV (APRV Group) (open circles ) or ventilated with a pressure-controlled, time-cycled me-chanical mode for 72 h and then weaned with APRV (PCV Group) (closed squares ). Values are mean Ϯ SEM. †p Ͻ 0.05 between groups, *p Ͻ 0.05 be-tween groups at the same time point, ‡p Ͻ0.05 compared with Days 1, 2, or 3 within the same group.V ·Putensen, Zech, Wrigge, et al.: Maintaining Spontaneous Breathing During APRV 47ratio and lower VA /T . The concomitant increase in CI and arterial oxygenation improved the relationship between tissue oxygen supply and demand; O 2 remained unchanged despite the work of spontaneous breathing. In contrast, controlled me-chanical ventilation for 72 h followed by weaning with APRV effected slower improvement in cardiopulmonary function and was associated with an increased duration of ventilatory support and stay in the ICU.Patients with multiple trauma are considered at risk for de-velopment of ARDS. Hudson and coworkers (4) observed a 50% incidence of ARDS in trauma victims with an ISS above 50. The high incidence of ALI and ARDS in our trauma pa-tients, who had an average ISS of 50, is in agreement with these findings. Controlled mechanical ventilation has been claimed superior to unsupported spontaneous breathing in the prevention of severe pulmonary dysfunction and arterial hy-poxemia following trauma (23). On the other hand, arterialhypoxemia caused by VA /T during ARDS has been found to correlate directly with the quantity of nonaerated tissue ob-served by computed tomography in dependent lung regions adjacent to the diaphragm. These observations have been at-tributed to alveolar collapse caused by the superimposed pres-sure on the lung and a cephalad shift of the diaphragm most evident in dependent lung areas during mechanical ventilation (1). Persisting spontaneous breathing during ventilatory sup-port has been considered to improve both the distribution of ventilation to dependent lung areas and gas exchange, pre-sumably by diaphragmatic contraction opposing alveolar com-pression (8, 11). This may explain why our patients, during full ventilatory support, had a lower Pa O 2/F I O 2 ratio and thereby fulfilled the criteria for ARDS. However, ALI and ARDS·Q ·Q V ··Q ·Q only represent different levels of pulmonary gas exchange dis-turbance caused by the same inflammatory reaction leading to increased vascular and alveolar permeability, interstitial edema formation, and alveolar collapse (13).Partial ventilatory support is used increasingly, not only to wean patients from mechanical ventilation, but to provide sta-ble ventilatory assistance of a desired degree during ventilatory failure (11, 24). Spontaneous breathing in any phase of the me-chanical ventilator cycle is possible with APRV that provides ventilatory support by time-cycled switching between two levels of CPAP (9, 10). When spontaneous breathing is abolished,APRV is not different from conventional PCV (9–11). Ventila-Figure 5.Daily dose of intravenously administered norepinephrine, dobutamine, sufentanil, and midazolam at baseline (BL) and for 10 d in pa-tients immediately breathing spontaneously with APRV (APRV Group) (open circles ) or ventilated with a pressure-controlled, time-cycled mechani-cal mode for 72 h and then weaned with APRV (PCV Group) (closed squares ). Values are mean Ϯ SEM. †p Ͻ 0.05 between groups, *p Ͻ 0.05 be-tween groups at the same time point, ‡p Ͻ 0.05 compared with Days 1, 2, or 3 within the same group.TABLE 2.OUTCOME DATA*APRV GroupPCV Group p Value Number of patients, n (%)15 (100)15 (100)–Survivors, n (%)12 (80)11 (74)ns ARDS, n (%)3 (20)11 (74)0.015ALI non ARDS, n (%)8 (53) 4 (27)0.019Extrapulmonary organ failure, n (%)†18 (53)10 (67)ns 2 6 (38)7 (47)ns у 31 (9)0 (0)ns Sepsis, n (%)9 (75)10 (30)ns Length of ventilatory support, d 15 Ϯ 2 21 Ϯ 20.032Length of intubation, d 18 Ϯ 225 Ϯ 20.011Length of ICU stay, d23 Ϯ 230 Ϯ 20.032Definition of abbreviations : ALI ϭ acute lung injury (13); ARDS ϭ acute respiratory dis-tress syndrome (13); F ϭ female; M ϭ male.* Values are mean Ϯ SEM.†Defined by the multi-organ failure score described by Knaus and colleagues (15)48AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 1642001tory support during APRV is determined by pulmonary me-chanics, ventilatory rate, and the degree of spontaneous breath-ing. Consequently, in the absence of spontaneous breathing during APRV, lower alveolar ventilation results in a high Pa CO 2and low pH unless the airway pressure limits are adjusted toproduce a larger V T and acceptable Pa CO 2 and pH. Therefore,to maintain, E , Pa CO 2, and pH in the absence of spontaneous breathing, the pressure support level had to be significantly in-creased, and to prevent upper airway pressure from exceeding UIP, the ventilatory rate had to be significantly increased. Pri-marily partial ventilatory support with APRV allowed earlier discontinuation of ventilatory support, which was achieved by decreasing the ventilatory rate. Recent in v itro experiments suggest that decreasing ventilatory rates may even play a role in preventing ventilator-associated lung damage (25).Several studies have documented improved pulmonary gas exchange upon changeover from full to partial ventilatory sup-port (11, 24, 26). Prospective randomized trials indicate that the type of partial ventilatory support has little or no effect on the efficiency of weaning from mechanically ventilation (22,27). Previous investigations have compared different partial ventilatory support modalities after prolonged mechanical ventilation in patients whose pulmonary function and gas ex-change had essentially recovered (22, 27). Furthermore, the effects of full versus partial ventilatory support on cardiopul-monary function are difficult to evaluate on the basis of previ-ous studies, because the modalities of mechanical ventilation were changed during the investigations (22, 27). In our study,the type of ventilatory support remained unchanged while the presence of spontaneous breathing was controlled with seda-tion and neuromuscular blockade and E remained constant.Therefore, our results should reflect essentially the effect of persisting spontaneous breathing, not that of a change in me-chanical ventilatory support modality.Early spontaneous breathing during APRV consistently re-sulted in improved VA /T and arterial blood oxygenation.These observations are in agreement with experimental (5, 6)and clinical (11, 24) findings that spontaneous breathing with APRV improves arterial blood oxygenation by decreasing in-trapulmonary shunting. Previous radiographic observations have demonstrated that contractions of the diaphragm favor distribution of ventilation to dependent, well-perfused lungareas (8). Reduction of VA /T in the presence of an increas-ing lung compliance indicates that spontaneous breathing with APRV improved the ventilation of initially nonventilated or poorly ventilated lung areas. In accordance with our findings,diaphragmatic contractions have been shown to reduce the size of atelectasis in dependent lung areas during general an-esthesia (28). Spontaneous breathing should be associated with an increase in transpulmonary pressure caused by dia-phragmatic contractions, and should therefore effectively re-cruit atelectatic lung regions or prevent progressive alveolar collapse in patients at risk for ARDS.By contrast, full ventilatory support in anesthetized and paralyzed patients with normal lung function has been shown to result in atelectasis in dependent lung regions, which con-tributes considerabley to VA /T (29). In accord with these observations (29), absence of spontaneous breathing during mechanical ventilation, induced by deep sedation and neuro-muscular blockade in our patients, promoted formation of atelectasis, presumably by a cephalad shift of the diaphragmand reflected by worsened lung compliance, VA /T , and ar-terial oxygenation. After 72 h of mechanical ventilation, spon-taneous breathing with APRV improved but did not restore gas exchange and lung mechanics.Deep sedation with neuromuscular blockade is generally V ·V ··Q ·Q ·Q ·Q ·Q ·Q ·Q ·Q used to adapt patients to controlled mechanical ventilation (30).In a previous study we distinguished between the effects of se-dation and neuromuscular blockade on gas exchange. Neuro-muscular blockade did not affect gas exchange in patients with severe ARDS who had been rendered apneic by reducing their Pa CO 2 (11). Therefore, the use of neuromuscular blockade to guarantee controlled mechanical ventilation cannot entirely ex-plain the changes in cardiopulmonary function observed with persisting spontaneous breathing during APRV. Sedation in our patients was titrated to suppress spontaneous breathing.Under this condition, midazolam and sufentanil inhibited respi-ratory muscle activity and should have reduced the tension of the diaphragm (31). The cephalad shift of the diaphragm caused by its reduced tension during deep sedation or anesthesia is not aggravated by neuromuscular blockade (32). In agreement with observations during anesthesia, even higher airway pressures during controlled mechanical ventilation cannot prevent the de-velopment of atelectasis and deterioration of gas exchange (33).This may explain the deterioration in gas exchange observed in our patients who received initial PCV with deep sedation. How-ever, the results of our study do not allow us to precisely distin-guish the effects on cardiopulmonary function of deep sedation from those of controlled mechanical ventilation.In our patients, spontaneous breathing was associated with an increase in CI. This is in agreement with the concept that a decrease in intrathoracic pressure during spontaneous inspira-tion with APRV may improve venous return and CI (11, 34).The highest CI values and lowest required doses of vasopres-sors and positive inotropes in our study occurred with persist-ing spontaneous breathing during APRV. The smaller increase in CI found when spontaneous breathing occurred after a pe-riod of controlled mechanical ventilation may be attributed to higher airway pressure support levels or deeper sedation. End-expiratory lung hyperinflation cannot explain this cardiovascu-lar finding, because PEEPi remained unchanged in both of our study groups. This indicates that during APRV, spontaneous respiratory activity may not decrease intrathoracic pressures sufficiently to entirely counteract the cardiovascular depres-sion caused by higher airway pressures or deeper sedation.Changes in CI caused by mechanical ventilation have beenreported to correlate positively with VA /T (35). In contrast,during spontaneous breathing with APRV, an increased CIwas associated with a smaller VA /T , an increased Pa O 2, and a considerably higher D O 2. This effect was less pronounced when spontaneous breathing with APRV was allowed after 72 h of controlled mechanical ventilation. In accordance with pre-vious findings (11, 24, 36), total O 2 was not measurably al-tered by spontaneous breathing in our patients. The compara-ble total O 2 indicates appropriate sedation levels in both of our study groups. An increased D O 2 with unchanged O 2 re-sulted in an improved relationship between tissue oxygen sup-ply and demand, as reflected by a significant decrease in O 2ER ,which also may have contributed to the higher Pa O 2 during APRV with spontaneous breathing.Primarily partial ventilatory support with APRV was con-sistently associated with a shorter duration of ventilatory sup-port, intubation, and ICU stay. This presumably results from the improvement in cardiopulmonary function with persisting spontaneous breathing without excessive sedation. Previous in-vestigations demonstrated that standardized weaning protocols allow early identification of patients for spontaneous breathing trials, and thereby reduce the duration of mechanical ventila-tion (22). Because identical protocols were used to discontinue ventilatory support in both of our study groups, our results sug-gest that persisting spontaneous breathing with APRV is effi-cient for reducing the duration of ventilatory support. Hsiang·Q ·Q ·Q ·Q V ·V ·V ·。

相关文档
最新文档